Nuvectis Pharma Debt
NVCT Stock | USD 4.90 0.17 3.35% |
Net Debt is likely to drop to about (20.1 M) in 2024. Net Debt To EBITDA is likely to drop to 0.62 in 2024. Nuvectis Pharma's financial risk is the risk to Nuvectis Pharma stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Nuvectis |
Nuvectis Pharma Debt to Cash Allocation
Nuvectis Pharma currently holds 6.98 M in liabilities. Nuvectis Pharma has a current ratio of 5.1, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Nuvectis Pharma's use of debt, we should always consider it together with its cash and equity.Nuvectis Pharma Total Assets Over Time
Nuvectis Pharma Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Nuvectis Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Nuvectis Pharma, which in turn will lower the firm's financial flexibility.Nuvectis Pharma Corporate Bonds Issued
Nuvectis Net Debt
Net Debt |
|
Understaning Nuvectis Pharma Use of Financial Leverage
Nuvectis Pharma's financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Nuvectis Pharma's current equity. If creditors own a majority of Nuvectis Pharma's assets, the company is considered highly leveraged. Understanding the composition and structure of Nuvectis Pharma's outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last Reported | Projected for Next Year | ||
Net Debt | -19.1 M | -20.1 M | |
Net Debt To EBITDA | 0.84 | 0.62 | |
Interest Debt Per Share | 0.01 | 0.01 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.